The following is a summary of “Associations of schizophrenia with arrhythmic disorders and electrocardiogram traits: genetic exploration of population samples,” published in the November 2024 issue of ...
Propafenone Hydrochlride, widely used in the treatment of cardiac arrhythmias, is a highdemand API with a current global market size of USD 1.2 billion.
The McGill University health Centre (MUHC) Foundation is thrilled to announce that Dr. Renzo Cecere, Cardiac Surgeon at the MUHC and Director of the Myocardial Regeneration Lab at the Research ...